Undiagnosed Sleep Disorder Market Offers Growth Opportunities

Table of Contents

1. Sleep Disorders: An Introduction

• 1.1 Sleep Cycle
• 1.2 Amount of Sleep Required
• 1.3 Sleep Disorders
• 1.4 Insomnia
• 1.5 Sleep Apnea
• 1.6 Narcolepsy
• 1.7 Restless Legs Syndrome
• 1.8 Treatment & Diagnosis

2. Market Overview

• 2.1 Worldwide Market
• 2.2 US Market

3. OSA Market

• 3.1 Sleep Disordered Breathing Market Breakup
• 3.2 US Market for OSA Treatment

4. Insomnia Market

5. Market Trends

• 5.1 Use of Actigraphy for Sleep Disorder Evaluation
• 5.2 Alternative Medicines for Insomnia
• 5.3 Opportunities for HME Providers
• 5.4 Increasing Sleep Centers

6. Demographic Trends

• 6.1 Sleep Disorders in Older People
• 6.2 Sleep Disorders in Women
• 6.3 Sleep Disorders in Children
• 6.4 Sleep Concerns of Employees

7. Competitive Landscape

• 7.1 Insomnia Market
  • 7.1.1 Drugs in Pipeline for Insomnia
  • 7.1.2 Insomnia Market Activity
  • 7.1.3 Marketers of Insomnia Drugs
  • 7.1.4 Insomnia Market Share
  • 7.1.5 Characteristics of Drugs
• 7.2 OSA Market
  • 7.2.1 OSA Sales & Market Share
  • 7.2.2 Worldwide Market
  • 7.2.3 US Market

8. Company Profiles

• 8.1 Respironics
  • 8.1.1 Overview
  • 8.1.2 Business Strategies
  • 8.1.3 Product Innovation
  • 8.1.4 Strong Distribution Network
  • 8.1.5 International Growth
• 8.2 ResMed
  • 8.2.1 Overview
  • 8.2.1 Business Strategies
  • 8.2.1 Continued Product Development and Innovation
  • 8.2.1 Increase Public and Clinical Awareness
  • 8.2.1 Expansion into New Clinical Applications
• 8.3 Neurocrine
  • 8.3.1 Overview
  • 8.3.2 Business Strategies
  • 8.3.3 Building Product Portfolio
  • 8.3.4 Identifying Novel Drug Targets
• 8.4 Neurogen
  • 8.4.1 Overview
  • 8.4.2 Business Strategies
  • 8.4.3 Pursue a Risk-balanced Drug Portfolio
  • 8.4.4 Partnering at Optimal Stages
  • 8.4.5 Focus on Specialist Care Indications

List of Charts

• Total Sleep/Day by Age Group
• Classification of Sleep Disorders
• Worldwide Market for Sleep Disorder Treatment (2004-10E)
• US Sleep Diagnostic/Treatment Device Market (2005-07E)
• US Market for OSA Treatment (2003-07E)
• Sleep Disordered Breathing Market Breakup
• Insomnia Market Share - Drug Classes (2006)
• Non-Benzo/Non-Barbituate Market Share (2007)

List of Tables

• Sleep Disorder Facilities in the US (1996-2007)
• Employees Survey - Causes of Sleep Disturbance
• Drugs in Pipeline for Insomnia
• Insomnia Market Activity (2007)
• Current/Potential Marketers of Insomnia Drugs
• Characteristics of Drugs Marketed For Insomnia
• OSA Market Leaders - Market Share (2005-09E)
• OSA Market Leaders -US & International Sales (2005-09E)
• ResMed - CPAP Products
• Neurocrine - Product Pipeline
• Neurogen - Clinical Development Programs